Joanne Foody
Chief Medical Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Esperion Therapeutics, Inc. (ESPR) | Chief Medical Officer | $388,288 | $1,870,559 |
| 2023 | Esperion Therapeutics, Inc. (ESPR) | Chief Medical Officer | $528,333 | $1,424,741 |
| 2022 | Esperion Therapeutics, Inc. (ESPR) | Chief Medical Officer | $505,000 | $1,531,159 |
| 2021 | Esperion Therapeutics, Inc. (ESPR) | Chief Medical Officer | $258,239 | $3,684,124 |
Earnings-call appearances
-
Esperion Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-07
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-07
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-09
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q4 FY2022 Earnings Call2023-01-09
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-01
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-02
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-03
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q4 FY2021 Earnings Call2022-01-11
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q3 FY2021 Earnings Call2021-10-18
Esperion Therapeutics, Inc. (ESPR)
-
Esperion Therapeutics, Inc. Q2 FY2021 Earnings Call2021-08-03
Esperion Therapeutics, Inc. (ESPR)